Galectin Therapeutics (GALT) May Have Best Read-Through From Allergan's Tobira (TBRA) Deal - H.C. Wainwright's Arce
- Wall St edges lower as rising yields overshadow upbeat corporate results
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Boeing reports first revenue drop in 7 quarters as deliveries decline
- Oil settles lower as U.S. business activity cools, concerns over Middle East ease
- Yen on the brink, but Tesla pulls back
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Hasbro (HAS) brand strength sees earnings top expectations
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
Galmed Pharma (GLMD) Adds to NASH-Frenzy Gains
September 22, 2016 3:28 PM EDTNASH stock Galmed Pharma (NASDAQ: GLMD) is pushing to the highs of the session. Shares are up 16.8% to $5.42, and up 43% since Tuesday when Allergan (NASDAQ: AGN) agreed to acquire Tobira Therapeutics (NASDAQ: TBRA) at a... More
Galectin Therapeutics (GALT) Adds to Recent Speculative Gains
September 22, 2016 8:19 AM EDTGalectin Therapeutics (NASDAQ: GALT) adds to recent gains amid NASH stock takeover speculation following Allergen's (NYSE: AGN) recent takeover of Tobira (NASDAQ: TBRA) at a huge... More
Galectin Therapeutics (GALT) Gains Again on Takeover, NASH Trial Speculation
September 21, 2016 10:53 AM EDTGalectin Therapeutics (NASDAQ: GALT) is surging higher again as speculators reprice NASH stocks following Allergen's (NYSE: AGN) takeover of Tobira (NASDAQ: TBRA) yesterday. Today, on its call, Allergan's CEO said Tobira was a 'very... More